- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Financial Performance: GPT Healthcare reported revenue from operations of INR 102 crore for Q3 FY '25, reflecting a 6% year-over-year increase. Profit after tax (PAT) also increased by 6% year-over-year to INR 12 crore. The company achieved an EBITDA of INR 23 crore, yielding an EBITDA margin of 22.7%. For the nine-month period, PAT totaled INR 37 crore, with a PAT margin of 12% and a 5.7% growth. Finance costs were reduced by 55% due to lower debt levels, while the average revenue per occupied bed (ARPOB) now stands at INR 36,700, with bed occupancy around 54%.
Future Outlook and Growth Drivers: Management expressed confidence in achieving their target of becoming a 1,000-bed hospital chain by FY '27. This includes the upcoming operational launch of a 152-bed facility in Raipur and the signing of an MOU for a 150-bed hospital in Jamshedpur, demonstrating ongoing expansion initiatives.
Order Book and Operational Updates: Notably, the Agartala Hospital is commencing full-fledged oncology services. The Dum Dum and Howrah hospitals have seen positive momentum in patient volumes, while ILS Hospital in Salt Lake has increased its ARPOB by 16.6% year-over-year.
Analyst Q&A Insights: Inquiries addressed growth factors contributing to ARPOB, including a focus on complex treatments and insurance rate renewals. Management acknowledged external challenges impacting productivity, citing regional incidents and floods, and reaffirmed a commitment to a 15% annual growth trajectory. The company's cash position of INR 45 crore supports its debt management strategy for future acquisitions.
Market or Regulatory Updates: While the company noted restrictions on international patient volumes from Bangladesh, they are exploring opportunities for medical tourism from nearby regions such as Bhutan.
Strategic Focus Areas: The management emphasized a commitment to quality healthcare in underserved regions, with strategic intent on maintaining a balance between premium and accessible care models.
Investor Insight: Given GPT Healthcare's solid financial performance, proactive expansion plans, and management's clear growth strategy, the outlook appears positive, suggesting a ‘buy’ or ‘hold’ position depending on individual risk tolerance and market conditions.